Skip to main content

Table 3 Univariate and multivariate analyses of  TTPR in the NACT cohort

From: Patients with macroscopic lymph node metastasis expect poor prognosis after neoadjuvant chemotherapy in advanced ovarian cancer: a retrospective cohort study based on a single gynecological team

Characteristics

Univariate

Multivariate

HR (95% CI)

P value

HR (95% CI)

P value

Age

0.978 (0.942–1.02)

0.252

0.985 (0.948–1.02)

0.415

CA125

1.00 (1.00–1.00)

0.493

  

BRCA mutationa

 No

Ref

   

 Yes

0.401 (0.135–1.19)

0.101

  

FIGO stage

 IIIC

Ref

 

Ref

 

 IV

0.662 (0.298–1.47)

0.311

0.489 (0.213–1.12)

0.091

NACT cycles

  ≤ 2

Ref

   

 3

0.54 (0.239–1.22)

0.138

  

  ≥ 4

0.97 (0.333–2.83)

0.955

  

LN status

 NLN

Ref

 

Ref

 

 MLN

2.13 (1.07–4.24)

0.0304

2.50 (1.22–5.13)

0.012

  1. aPatients with unknown BRCA mutation status were not included